My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 308

    1.

    In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci.

    El-Azizi M, Rao S, Kanchanapoom T, Khardori N.

    Ann Clin Microbiol Antimicrob. 2005 Jan 7;4:2.PMID: 15638934 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.

    Tünger A, Aydemir S, Uluer S, Cilli F.

    Indian J Med Res. 2004 Dec;120(6):546-52.PMID: 15654141 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains.

    Rybak MJ, Hershberger E, Moldovan T, Grucz RG.

    Antimicrob Agents Chemother. 2000 Apr;44(4):1062-6.PMID: 10722513 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    In vitro activity of gallium maltolate against Staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calorimetric susceptibility testing methods.

    Baldoni D, Steinhuber A, Zimmerli W, Trampuz A.

    Antimicrob Agents Chemother. 2010 Jan;54(1):157-63. Epub 2009 Oct 5.PMID: 19805560 [PubMed - indexed for MEDLINE]Related articles

    6.

    In vitro activity of telithromycin, quinupristin/dalfopristin, linezolid and comparator antimicrobial agents against Staphylococcus aureus clinical isolates.

    Millán L, Cerdá P, Rubio MC, Goñi P, Canales M, Capilla S, Oca M, Gómez-Lus R.

    J Chemother. 2004 Jun;16(3):230-7.PMID: 15330317 [PubMed - indexed for MEDLINE]Related articles

    8.

    In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.

    Harper T, Miller D, Flynn HW Jr.

    Ophthalmology. 2007 May;114(5):871-5. Epub 2007 Mar 26.PMID: 17383732 [PubMed - indexed for MEDLINE]Related articles

    10.

    Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.

    Wu JA, Kusuma C, Mond JJ, Kokai-Kun JF.

    Antimicrob Agents Chemother. 2003 Nov;47(11):3407-14.PMID: 14576095 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.

    Drago L, Nicola L, De Vecchi E.

    Clin Microbiol Infect. 2008 Jun;14(6):608-11. Epub 2008 Apr 5.PMID: 18397336 [PubMed - indexed for MEDLINE]Related articles

    14.

    Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.

    Baysallar M, Kilic A, Aydogan H, Cilli F, Doganci L.

    Int J Antimicrob Agents. 2004 May;23(5):510-2. Erratum in: Int J Antimicrob Agents. 2005 Jan;25(1):93. PMID: 15120733 [PubMed - indexed for MEDLINE]Related articles

    15.

    Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.

    Giacometti A, Cirioni O, Ghiselli R, Orlando F, Mocchegiani F, Silvestri C, Licci A, De Fusco M, Provinciali M, Saba V, Scalise G.

    Antimicrob Agents Chemother. 2005 Oct;49(10):4042-5.PMID: 16189078 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan.

    Luh KT, Hsueh PR, Teng LJ, Pan HJ, Chen YC, Lu JJ, Wu JJ, Ho SW.

    Antimicrob Agents Chemother. 2000 Dec;44(12):3374-80.PMID: 11083643 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates.

    Dowzicky M, Nadler HL, Feger C, Talbot G, Bompart F, Pease M.

    Am J Med. 1998 May 29;104(5A):34S-42S. Review.PMID: 9684656 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Activity and penetration of linezolid and vancomycin against Staphylococcus epidermidis biofilms]

    Rodríguez-Martínez JM, Ballesta S, García I, Conejo MC, Pascual A.

    Enferm Infecc Microbiol Clin. 2007 Aug-Sep;25(7):425-8. Spanish. PMID: 17692209 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk